APO Research
Talk to an analyst

APO RESEARCH · REPORT

Drugs of Abuse Testing Systems

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Drugs of Abuse Testing Systems Industry Growth and Trends Forecast to 2032

4 July 2026109 pages

Choose your research edition.

Industry ResearchDrugs of Abuse Testing Systems Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Drugs of Abuse Testing Systems Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Drugs of Abuse Testing Systems Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drugs of Abuse Testing Systems Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Drugs of Abuse Testing Systems Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Drugs of Abuse Testing Systems market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Drugs of Abuse Testing Systems is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Drugs of Abuse Testing Systems is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Drugs of Abuse Testing Systems is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Drugs of Abuse Testing Systems include Abbott, Thermo Fisher Scientific, Roche, Wondfo Biotech, Siemens Healthineers, Randox Laboratories, Orient Gene Biotech, OraSure and Intec, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Drugs of Abuse Testing Systems market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Drugs of Abuse Testing Systems market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Drugs of Abuse Testing Systems market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Drugs of Abuse Testing Systems.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Drugs of Abuse Testing Systems market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Drugs of Abuse Testing Systems Market by Company

Abbott

Thermo Fisher Scientific

Roche

Wondfo Biotech

Siemens Healthineers

Randox Laboratories

Orient Gene Biotech

OraSure

Intec

Hangzhou Biotest

Drager

Assure Tech (Hangzhou) Co

Aotai Bio

Drugs of Abuse Testing Systems Segment by Type

Urine Screening System

Saliva Test System

Others

Drugs of Abuse Testing Systems Segment by Application

Hospital

Laboratory

Others

Drugs of Abuse Testing Systems Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drugs of Abuse Testing Systems market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drugs of Abuse Testing Systems and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drugs of Abuse Testing Systems.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Drugs of Abuse Testing Systems manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Drugs of Abuse Testing Systems in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Urine Screening System Table 2. Major Company of Saliva Test System Table 3. Major Company of Others Table 4. Global Drugs of Abuse Testing Systems Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Drugs of Abuse Testing Systems Sales by Type (2021-2026) & (k units) Table 6. Global Drugs of Abuse Testing Systems Sales Market Share in Volume by Type (2021-2026) Table 7. Global Drugs of Abuse Testing Systems Sales by Type (2021-2026) & (US$ Million) Table 8. Global Drugs of Abuse Testing Systems Sales Market Share in Value by Type (2021-2026) Table 9. Global Drugs of Abuse Testing Systems Price by Type (2021-2026) & (USD/unit) Table 10. Global Drugs of Abuse Testing Systems Sales by Type (2027-2032) & (k units) Table 11. Global Drugs of Abuse Testing Systems Sales Market Share in Volume by Type (2027-2032) Table 12. Global Drugs of Abuse Testing Systems Sales by Type (2027-2032) & (US$ Million) Table 13. Global Drugs of Abuse Testing Systems Sales Market Share in Value by Type (2027-2032) Table 14. Global Drugs of Abuse Testing Systems Price by Type (2027-2032) & (USD/unit) Table 15. North America Drugs of Abuse Testing Systems Sales by Type (2021-2026) & (k units) Table 16. North America Drugs of Abuse Testing Systems Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Drugs of Abuse Testing Systems Sales by Type (2021-2026) & (k units) Table 18. Europe Drugs of Abuse Testing Systems Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Drugs of Abuse Testing Systems Sales by Type (2021-2026) & (k units) Table 20. Asia-Pacific Drugs of Abuse Testing Systems Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Drugs of Abuse Testing Systems Sales by Type (2021-2026) & (k units) Table 22. Latin America Drugs of Abuse Testing Systems Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Drugs of Abuse Testing Systems Sales by Type (2021-2026) & (k units) Table 24. Middle East and Africa Drugs of Abuse Testing Systems Sales by Type (2021-2026) & (US$ Million) Table 25. Drugs of Abuse Testing Systems Industry Trends Table 26. Drugs of Abuse Testing Systems Industry Drivers Table 27. Drugs of Abuse Testing Systems Industry Opportunities and Challenges Table 28. Drugs of Abuse Testing Systems Industry Restraints Table 29. Global Drugs of Abuse Testing Systems Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Drugs of Abuse Testing Systems Revenue Market Share by Company (2021-2026) Table 31. Global Drugs of Abuse Testing Systems Sales by Company (2021-2026) & (k units) Table 32. Global Drugs of Abuse Testing Systems Sales Share by Company (2021-2026) Table 33. Global Drugs of Abuse Testing Systems Market Price by Company (2021-2026) & (USD/unit) Table 34. Global Drugs of Abuse Testing Systems Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Drugs of Abuse Testing Systems Major Company Production Sites and Headquarters Table 36. Global Drugs of Abuse Testing Systems Company, Product Type & Application Table 37. Global Drugs of Abuse Testing Systems Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Drugs of Abuse Testing Systems by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Drugs of Abuse Testing Systems Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Drugs of Abuse Testing Systems Sales by Region (2021-2026) & (k units) Table 42. Global Drugs of Abuse Testing Systems Sales Market Share in Volume by Region (2021-2026) Table 43. Global Drugs of Abuse Testing Systems Sales by Region (2021-2026) & (US$ Million) Table 44. Global Drugs of Abuse Testing Systems Sales Market Share in Value by Region (2021-2026) Table 45. Global Drugs of Abuse Testing Systems Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 46. Global Drugs of Abuse Testing Systems Sales by Region (2027-2032) & (k units) Table 47. Global Drugs of Abuse Testing Systems Sales Market Share in Volume by Region (2027-2032) Table 48. Global Drugs of Abuse Testing Systems Sales by Region (2027-2032) & (US$ Million) Table 49. Global Drugs of Abuse Testing Systems Sales Market Share in Value by Region (2027-2032) Table 50. Global Drugs of Abuse Testing Systems Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2027-2032) Table 51. Global Drugs of Abuse Testing Systems Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Drugs of Abuse Testing Systems Sales by Application (2021-2026) & (k units) Table 53. Global Drugs of Abuse Testing Systems Sales Market Share in Volume by Application (2021-2026) Table 54. Global Drugs of Abuse Testing Systems Sales by Application (2021-2026) & (US$ Million) Table 55. Global Drugs of Abuse Testing Systems Sales Market Share in Value by Application (2021-2026) Table 56. Global Drugs of Abuse Testing Systems Price by Application (2021-2026) & (USD/unit) Table 57. Global Drugs of Abuse Testing Systems Sales by Application (2027-2032) & (k units) Table 58. Global Drugs of Abuse Testing Systems Sales Market Share in Volume by Application (2027-2032) Table 59. Global Drugs of Abuse Testing Systems Sales by Application (2027-2032) & (US$ Million) Table 60. Global Drugs of Abuse Testing Systems Sales Market Share in Value by Application (2027-2032) Table 61. Global Drugs of Abuse Testing Systems Price by Application (2027-2032) & (USD/unit) Table 62. North America Drugs of Abuse Testing Systems Sales by Application (2021-2026) & (k units) Table 63. North America Drugs of Abuse Testing Systems Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Drugs of Abuse Testing Systems Sales by Application (2021-2026) & (k units) Table 65. Europe Drugs of Abuse Testing Systems Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Drugs of Abuse Testing Systems Sales by Application (2021-2026) & (k units) Table 67. Asia-Pacific Drugs of Abuse Testing Systems Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Drugs of Abuse Testing Systems Sales by Application (2021-2026) & (k units) Table 69. Latin America Drugs of Abuse Testing Systems Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Drugs of Abuse Testing Systems Sales by Application (2021-2026) & (k units) Table 71. Middle East and Africa Drugs of Abuse Testing Systems Sales by Application (2021-2026) & (US$ Million) Table 72. Abbott Company Information Table 73. Abbott Business Overview Table 74. Abbott Drugs of Abuse Testing Systems Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 75. Abbott Drugs of Abuse Testing Systems Product Portfolio Table 76. Abbott Recent Development Table 77. Thermo Fisher Scientific Company Information Table 78. Thermo Fisher Scientific Business Overview Table 79. Thermo Fisher Scientific Drugs of Abuse Testing Systems Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 80. Thermo Fisher Scientific Drugs of Abuse Testing Systems Product Portfolio Table 81. Thermo Fisher Scientific Recent Development Table 82. Roche Company Information Table 83. Roche Business Overview Table 84. Roche Drugs of Abuse Testing Systems Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 85. Roche Drugs of Abuse Testing Systems Product Portfolio Table 86. Roche Recent Development Table 87. Wondfo Biotech Company Information Table 88. Wondfo Biotech Business Overview Table 89. Wondfo Biotech Drugs of Abuse Testing Systems Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. Wondfo Biotech Drugs of Abuse Testing Systems Product Portfolio Table 91. Wondfo Biotech Recent Development Table 92. Siemens Healthineers Company Information Table 93. Siemens Healthineers Business Overview Table 94. Siemens Healthineers Drugs of Abuse Testing Systems Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Siemens Healthineers Drugs of Abuse Testing Systems Product Portfolio Table 96. Siemens Healthineers Recent Development Table 97. Randox Laboratories Company Information Table 98. Randox Laboratories Business Overview Table 99. Randox Laboratories Drugs of Abuse Testing Systems Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Randox Laboratories Drugs of Abuse Testing Systems Product Portfolio Table 101. Randox Laboratories Recent Development Table 102. Orient Gene Biotech Company Information Table 103. Orient Gene Biotech Business Overview Table 104. Orient Gene Biotech Drugs of Abuse Testing Systems Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Orient Gene Biotech Drugs of Abuse Testing Systems Product Portfolio Table 106. Orient Gene Biotech Recent Development Table 107. OraSure Company Information Table 108. OraSure Business Overview Table 109. OraSure Drugs of Abuse Testing Systems Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. OraSure Drugs of Abuse Testing Systems Product Portfolio Table 111. OraSure Recent Development Table 112. Intec Company Information Table 113. Intec Business Overview Table 114. Intec Drugs of Abuse Testing Systems Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. Intec Drugs of Abuse Testing Systems Product Portfolio Table 116. Intec Recent Development Table 117. Hangzhou Biotest Company Information Table 118. Hangzhou Biotest Business Overview Table 119. Hangzhou Biotest Drugs of Abuse Testing Systems Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. Hangzhou Biotest Drugs of Abuse Testing Systems Product Portfolio Table 121. Hangzhou Biotest Recent Development Table 122. Drager Company Information Table 123. Drager Business Overview Table 124. Drager Drugs of Abuse Testing Systems Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. Drager Drugs of Abuse Testing Systems Product Portfolio Table 126. Drager Recent Development Table 127. Assure Tech (Hangzhou) Co Company Information Table 128. Assure Tech (Hangzhou) Co Business Overview Table 129. Assure Tech (Hangzhou) Co Drugs of Abuse Testing Systems Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 130. Assure Tech (Hangzhou) Co Drugs of Abuse Testing Systems Product Portfolio Table 131. Assure Tech (Hangzhou) Co Recent Development Table 132. Aotai Bio Company Information Table 133. Aotai Bio Business Overview Table 134. Aotai Bio Drugs of Abuse Testing Systems Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 135. Aotai Bio Drugs of Abuse Testing Systems Product Portfolio Table 136. Aotai Bio Recent Development Table 137. North America Drugs of Abuse Testing Systems Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 138. North America Drugs of Abuse Testing Systems Sales by Country (2021-2026) & (k units) Table 139. North America Drugs of Abuse Testing Systems Sales Market Share by Country (2021-2026) Table 140. North America Drugs of Abuse Testing Systems Sales Forecast by Country (2027-2032) & (k units) Table 141. North America Drugs of Abuse Testing Systems Sales Market Share Forecast by Country (2027-2032) Table 142. North America Drugs of Abuse Testing Systems Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. North America Drugs of Abuse Testing Systems Market Size by Country (2021-2026) & (US$ Million) Table 144. North America Drugs of Abuse Testing Systems Market Share by Country (2021-2026) Table 145. North America Drugs of Abuse Testing Systems Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. North America Drugs of Abuse Testing Systems Market Share Forecast by Country (2027-2032) Table 147. Europe Drugs of Abuse Testing Systems Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 148. Europe Drugs of Abuse Testing Systems Sales by Country (2021-2026) & (k units) Table 149. Europe Drugs of Abuse Testing Systems Sales Market Share by Country (2021-2026) Table 150. Europe Drugs of Abuse Testing Systems Sales Forecast by Country (2027-2032) & (k units) Table 151. Europe Drugs of Abuse Testing Systems Sales Market Share Forecast by Country (2027-2032) Table 152. Europe Drugs of Abuse Testing Systems Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Europe Drugs of Abuse Testing Systems Market Size by Country (2021-2026) & (US$ Million) Table 154. Europe Drugs of Abuse Testing Systems Market Share by Country (2021-2026) Table 155. Europe Drugs of Abuse Testing Systems Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Europe Drugs of Abuse Testing Systems Market Share Forecast by Country (2027-2032) Table 157. Asia-Pacific Drugs of Abuse Testing Systems Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 158. Asia-Pacific Drugs of Abuse Testing Systems Sales by Country (2021-2026) & (k units) Table 159. Asia-Pacific Drugs of Abuse Testing Systems Sales Market Share by Country (2021-2026) Table 160. Asia-Pacific Drugs of Abuse Testing Systems Sales Forecast by Country (2027-2032) & (k units) Table 161. Asia-Pacific Drugs of Abuse Testing Systems Sales Market Share Forecast by Country (2027-2032) Table 162. Asia-Pacific Drugs of Abuse Testing Systems Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Asia-Pacific Drugs of Abuse Testing Systems Market Size by Country (2021-2026) & (US$ Million) Table 164. Asia-Pacific Drugs of Abuse Testing Systems Market Share by Country (2021-2026) Table 165. Asia-Pacific Drugs of Abuse Testing Systems Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Asia-Pacific Drugs of Abuse Testing Systems Market Share Forecast by Country (2027-2032) Table 167. Latin America Drugs of Abuse Testing Systems Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 168. Latin America Drugs of Abuse Testing Systems Sales by Country (2021-2026) & (k units) Table 169. Latin America Drugs of Abuse Testing Systems Sales Market Share by Country (2021-2026) Table 170. Latin America Drugs of Abuse Testing Systems Sales Forecast by Country (2027-2032) & (k units) Table 171. Latin America Drugs of Abuse Testing Systems Sales Market Share Forecast by Country (2027-2032) Table 172. Latin America Drugs of Abuse Testing Systems Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. Latin America Drugs of Abuse Testing Systems Market Size by Country (2021-2026) & (US$ Million) Table 174. Latin America Drugs of Abuse Testing Systems Market Share by Country (2021-2026) Table 175. Latin America Drugs of Abuse Testing Systems Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. Latin America Drugs of Abuse Testing Systems Market Share Forecast by Country (2027-2032) Table 177. Middle East and Africa Drugs of Abuse Testing Systems Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 178. Middle East and Africa Drugs of Abuse Testing Systems Sales by Country (2021-2026) & (k units) Table 179. Middle East and Africa Drugs of Abuse Testing Systems Sales Market Share by Country (2021-2026) Table 180. Middle East and Africa Drugs of Abuse Testing Systems Sales Forecast by Country (2027-2032) & (k units) Table 181. Middle East and Africa Drugs of Abuse Testing Systems Sales Market Share Forecast by Country (2027-2032) Table 182. Middle East and Africa Drugs of Abuse Testing Systems Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 183. Middle East and Africa Drugs of Abuse Testing Systems Market Size by Country (2021-2026) & (US$ Million) Table 184. Middle East and Africa Drugs of Abuse Testing Systems Market Share by Country (2021-2026) Table 185. Middle East and Africa Drugs of Abuse Testing Systems Market Size Forecast by Country (2027-2032) & (US$ Million) Table 186. Middle East and Africa Drugs of Abuse Testing Systems Market Share Forecast by Country (2027-2032) Table 187. Key Raw Materials Table 188. Raw Materials Key Suppliers Table 189. Drugs of Abuse Testing Systems Distributors List Table 190. Drugs of Abuse Testing Systems Customers List Table 191. Research Programs/Design for This Report Table 192. Authors List of This Report Table 193. Secondary Sources Table 194. Primary Sources List of Figures Figure 1. Drugs of Abuse Testing Systems Image Figure 2. Global Drugs of Abuse Testing Systems Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Drugs of Abuse Testing Systems Market Size (2021-2032) & (US$ Million) Figure 4. Global Drugs of Abuse Testing Systems Sales (2021-2032) & (k units) Figure 5. Urine Screening System Image Figure 6. Global Urine Screening System Sales YoY Growth (2021-2032) & (k units) Figure 7. Saliva Test System Image Figure 8. Global Saliva Test System Sales YoY Growth (2021-2032) & (k units) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 11. Global Drugs of Abuse Testing Systems Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Drugs of Abuse Testing Systems Market Share by Type 2025 VS 2032 Figure 13. North America Drugs of Abuse Testing Systems Sales Market Share in Volume by Type in 2025 Figure 14. North America Drugs of Abuse Testing Systems Sales Market Share in Value by Type in 2025 Figure 15. Europe Drugs of Abuse Testing Systems Sales Market Share in Volume by Type in 2025 Figure 16. Europe Drugs of Abuse Testing Systems Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Drugs of Abuse Testing Systems Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Drugs of Abuse Testing Systems Sales Market Share in Value by Type in 2025 Figure 19. Latin America Drugs of Abuse Testing Systems Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Drugs of Abuse Testing Systems Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Drugs of Abuse Testing Systems Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Drugs of Abuse Testing Systems Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Drugs of Abuse Testing Systems Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospital Image Figure 26. Global Hospital Sales YoY Growth (2021-2032) & (k units) Figure 27. Laboratory Image Figure 28. Global Laboratory Sales YoY Growth (2021-2032) & (k units) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 31. Global Drugs of Abuse Testing Systems Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Drugs of Abuse Testing Systems Market Share by Application 2025 VS 2032 Figure 33. North America Drugs of Abuse Testing Systems Sales Market Share in Volume by Application in 2025 Figure 34. North America Drugs of Abuse Testing Systems Sales Market Share in Value by Application in 2025 Figure 35. Europe Drugs of Abuse Testing Systems Sales Market Share in Volume by Application in 2025 Figure 36. Europe Drugs of Abuse Testing Systems Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Drugs of Abuse Testing Systems Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Drugs of Abuse Testing Systems Sales Market Share in Value by Application in 2025 Figure 39. Latin America Drugs of Abuse Testing Systems Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Drugs of Abuse Testing Systems Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Drugs of Abuse Testing Systems Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Drugs of Abuse Testing Systems Sales Market Share in Value by Application in 2025 Figure 43. North America Drugs of Abuse Testing Systems Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. North America Drugs of Abuse Testing Systems Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Drugs of Abuse Testing Systems Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Drugs of Abuse Testing Systems Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Drugs of Abuse Testing Systems Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Europe Drugs of Abuse Testing Systems Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Drugs of Abuse Testing Systems Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Drugs of Abuse Testing Systems Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Drugs of Abuse Testing Systems Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Asia-Pacific Drugs of Abuse Testing Systems Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Drugs of Abuse Testing Systems Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Drugs of Abuse Testing Systems Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Drugs of Abuse Testing Systems Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Latin America Drugs of Abuse Testing Systems Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Drugs of Abuse Testing Systems Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Drugs of Abuse Testing Systems Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Drugs of Abuse Testing Systems Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Middle East and Africa Drugs of Abuse Testing Systems Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Drugs of Abuse Testing Systems Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Drugs of Abuse Testing Systems Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Drugs of Abuse Testing Systems Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Drugs of Abuse Testing Systems Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Urine Screening System
  • Saliva Test System
  • Others
Applications
  • Hospital
  • Laboratory
  • Others
Companies covered
  • Abbott
  • Thermo Fisher Scientific
  • Roche
  • Wondfo Biotech
  • Siemens Healthineers
  • Randox Laboratories
  • Orient Gene Biotech
  • OraSure
  • Intec
  • Hangzhou Biotest
  • Drager
  • Assure Tech (Hangzhou) Co
  • Aotai Bio

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Drugs of Abuse Testing Systems Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Drugs of Abuse Testing Systems Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Drugs of Abuse Testing Systems Market by Type
  6. 1.3.1 Urine Screening System
  7. 1.3.2 Saliva Test System
  8. 1.3.3 Others
  9. 1.4 Global Drugs of Abuse Testing Systems Market Size by Type
  10. 1.4.1 Global Drugs of Abuse Testing Systems Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Drugs of Abuse Testing Systems Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Drugs of Abuse Testing Systems Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Drugs of Abuse Testing Systems Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Drugs of Abuse Testing Systems Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Drugs of Abuse Testing Systems Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Drugs of Abuse Testing Systems Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Drugs of Abuse Testing Systems Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Drugs of Abuse Testing Systems Industry Trends
  2. 2.2 Drugs of Abuse Testing Systems Industry Drivers
  3. 2.3 Drugs of Abuse Testing Systems Industry Opportunities and Challenges
  4. 2.4 Drugs of Abuse Testing Systems Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Drugs of Abuse Testing Systems Revenue (2021-2026)
  2. 3.2 Global Top Players by Drugs of Abuse Testing Systems Sales (2021-2026)
  3. 3.3 Global Top Players by Drugs of Abuse Testing Systems Price (2021-2026)
  4. 3.4 Global Drugs of Abuse Testing Systems Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Drugs of Abuse Testing Systems Major Company Production Sites & Headquarters
  6. 3.6 Global Drugs of Abuse Testing Systems Company, Product Type & Application
  7. 3.7 Global Drugs of Abuse Testing Systems Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Drugs of Abuse Testing Systems Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Drugs of Abuse Testing Systems Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Drugs of Abuse Testing Systems Tier 1, Tier 2, and Tier 3
4 Drugs of Abuse Testing Systems Regional Status and Outlook
  1. 4.1 Global Drugs of Abuse Testing Systems Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Drugs of Abuse Testing Systems Historic Market Size by Region
  3. 4.2.1 Global Drugs of Abuse Testing Systems Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Drugs of Abuse Testing Systems Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Drugs of Abuse Testing Systems Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Drugs of Abuse Testing Systems Forecasted Market Size by Region
  7. 4.3.1 Global Drugs of Abuse Testing Systems Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Drugs of Abuse Testing Systems Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Drugs of Abuse Testing Systems Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Drugs of Abuse Testing Systems by Application
  1. 5.1 Drugs of Abuse Testing Systems Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Laboratory
  4. 5.1.3 Others
  5. 5.2 Global Drugs of Abuse Testing Systems Market Size by Application
  6. 5.2.1 Global Drugs of Abuse Testing Systems Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Drugs of Abuse Testing Systems Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Drugs of Abuse Testing Systems Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Drugs of Abuse Testing Systems Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Drugs of Abuse Testing Systems Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Drugs of Abuse Testing Systems Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Drugs of Abuse Testing Systems Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Drugs of Abuse Testing Systems Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Abbott
  2. 6.1.1 Abbott Company Information
  3. 6.1.2 Abbott Business Overview
  4. 6.1.3 Abbott Drugs of Abuse Testing Systems Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Abbott Drugs of Abuse Testing Systems Product Portfolio
  6. 6.1.5 Abbott Recent Developments
  7. 6.2 Thermo Fisher Scientific
  8. 6.2.1 Thermo Fisher Scientific Company Information
  9. 6.2.2 Thermo Fisher Scientific Business Overview
  10. 6.2.3 Thermo Fisher Scientific Drugs of Abuse Testing Systems Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Thermo Fisher Scientific Drugs of Abuse Testing Systems Product Portfolio
  12. 6.2.5 Thermo Fisher Scientific Recent Developments
  13. 6.3 Roche
  14. 6.3.1 Roche Company Information
  15. 6.3.2 Roche Business Overview
  16. 6.3.3 Roche Drugs of Abuse Testing Systems Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Roche Drugs of Abuse Testing Systems Product Portfolio
  18. 6.3.5 Roche Recent Developments
  19. 6.4 Wondfo Biotech
  20. 6.4.1 Wondfo Biotech Company Information
  21. 6.4.2 Wondfo Biotech Business Overview
  22. 6.4.3 Wondfo Biotech Drugs of Abuse Testing Systems Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Wondfo Biotech Drugs of Abuse Testing Systems Product Portfolio
  24. 6.4.5 Wondfo Biotech Recent Developments
  25. 6.5 Siemens Healthineers
  26. 6.5.1 Siemens Healthineers Company Information
  27. 6.5.2 Siemens Healthineers Business Overview
  28. 6.5.3 Siemens Healthineers Drugs of Abuse Testing Systems Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Siemens Healthineers Drugs of Abuse Testing Systems Product Portfolio
  30. 6.5.5 Siemens Healthineers Recent Developments
  31. 6.6 Randox Laboratories
  32. 6.6.1 Randox Laboratories Company Information
  33. 6.6.2 Randox Laboratories Business Overview
  34. 6.6.3 Randox Laboratories Drugs of Abuse Testing Systems Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Randox Laboratories Drugs of Abuse Testing Systems Product Portfolio
  36. 6.6.5 Randox Laboratories Recent Developments
  37. 6.7 Orient Gene Biotech
  38. 6.7.1 Orient Gene Biotech Company Information
  39. 6.7.2 Orient Gene Biotech Business Overview
  40. 6.7.3 Orient Gene Biotech Drugs of Abuse Testing Systems Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Orient Gene Biotech Drugs of Abuse Testing Systems Product Portfolio
  42. 6.7.5 Orient Gene Biotech Recent Developments
  43. 6.8 OraSure
  44. 6.8.1 OraSure Company Information
  45. 6.8.2 OraSure Business Overview
  46. 6.8.3 OraSure Drugs of Abuse Testing Systems Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 OraSure Drugs of Abuse Testing Systems Product Portfolio
  48. 6.8.5 OraSure Recent Developments
  49. 6.9 Intec
  50. 6.9.1 Intec Company Information
  51. 6.9.2 Intec Business Overview
  52. 6.9.3 Intec Drugs of Abuse Testing Systems Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Intec Drugs of Abuse Testing Systems Product Portfolio
  54. 6.9.5 Intec Recent Developments
  55. 6.10 Hangzhou Biotest
  56. 6.10.1 Hangzhou Biotest Company Information
  57. 6.10.2 Hangzhou Biotest Business Overview
  58. 6.10.3 Hangzhou Biotest Drugs of Abuse Testing Systems Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Hangzhou Biotest Drugs of Abuse Testing Systems Product Portfolio
  60. 6.10.5 Hangzhou Biotest Recent Developments
  61. 6.11 Drager
  62. 6.11.1 Drager Company Information
  63. 6.11.2 Drager Business Overview
  64. 6.11.3 Drager Drugs of Abuse Testing Systems Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Drager Drugs of Abuse Testing Systems Product Portfolio
  66. 6.11.5 Drager Recent Developments
  67. 6.12 Assure Tech (Hangzhou) Co
  68. 6.12.1 Assure Tech (Hangzhou) Co Company Information
  69. 6.12.2 Assure Tech (Hangzhou) Co Business Overview
  70. 6.12.3 Assure Tech (Hangzhou) Co Drugs of Abuse Testing Systems Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Assure Tech (Hangzhou) Co Drugs of Abuse Testing Systems Product Portfolio
  72. 6.12.5 Assure Tech (Hangzhou) Co Recent Developments
  73. 6.13 Aotai Bio
  74. 6.13.1 Aotai Bio Company Information
  75. 6.13.2 Aotai Bio Business Overview
  76. 6.13.3 Aotai Bio Drugs of Abuse Testing Systems Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Aotai Bio Drugs of Abuse Testing Systems Product Portfolio
  78. 6.13.5 Aotai Bio Recent Developments
7 North America by Country
  1. 7.1 North America Drugs of Abuse Testing Systems Sales by Country
  2. 7.1.1 North America Drugs of Abuse Testing Systems Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Drugs of Abuse Testing Systems Sales by Country (2021-2026)
  4. 7.1.3 North America Drugs of Abuse Testing Systems Sales Forecast by Country (2027-2032)
  5. 7.2 North America Drugs of Abuse Testing Systems Market Size by Country
  6. 7.2.1 North America Drugs of Abuse Testing Systems Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Drugs of Abuse Testing Systems Market Size by Country (2021-2026)
  8. 7.2.3 North America Drugs of Abuse Testing Systems Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Drugs of Abuse Testing Systems Sales by Country
  2. 8.1.1 Europe Drugs of Abuse Testing Systems Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Drugs of Abuse Testing Systems Sales by Country (2021-2026)
  4. 8.1.3 Europe Drugs of Abuse Testing Systems Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Drugs of Abuse Testing Systems Market Size by Country
  6. 8.2.1 Europe Drugs of Abuse Testing Systems Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Drugs of Abuse Testing Systems Market Size by Country (2021-2026)
  8. 8.2.3 Europe Drugs of Abuse Testing Systems Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Drugs of Abuse Testing Systems Sales by Country
  2. 9.1.1 Asia-Pacific Drugs of Abuse Testing Systems Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Drugs of Abuse Testing Systems Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Drugs of Abuse Testing Systems Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Drugs of Abuse Testing Systems Market Size by Country
  6. 9.2.1 Asia-Pacific Drugs of Abuse Testing Systems Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Drugs of Abuse Testing Systems Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Drugs of Abuse Testing Systems Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Drugs of Abuse Testing Systems Sales by Country
  2. 10.1.1 South America Drugs of Abuse Testing Systems Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Drugs of Abuse Testing Systems Sales by Country (2021-2026)
  4. 10.1.3 South America Drugs of Abuse Testing Systems Sales Forecast by Country (2027-2032)
  5. 10.2 South America Drugs of Abuse Testing Systems Market Size by Country
  6. 10.2.1 South America Drugs of Abuse Testing Systems Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Drugs of Abuse Testing Systems Market Size by Country (2021-2026)
  8. 10.2.3 South America Drugs of Abuse Testing Systems Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Drugs of Abuse Testing Systems Sales by Country
  2. 11.1.1 Middle East and Africa Drugs of Abuse Testing Systems Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Drugs of Abuse Testing Systems Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Drugs of Abuse Testing Systems Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Drugs of Abuse Testing Systems Market Size by Country
  6. 11.2.1 Middle East and Africa Drugs of Abuse Testing Systems Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Drugs of Abuse Testing Systems Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Drugs of Abuse Testing Systems Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Drugs of Abuse Testing Systems Value Chain Analysis
  2. 12.1.1 Drugs of Abuse Testing Systems Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Drugs of Abuse Testing Systems Production Mode & Process
  7. 12.2 Drugs of Abuse Testing Systems Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Drugs of Abuse Testing Systems Distributors
  10. 12.2.3 Drugs of Abuse Testing Systems Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst